Dr. Gerard Philip Aurigemma, MD

Dr. Aurigemma practices at Umass Memorial Medical Center in Mendon, Massachusetts.

Dr. Aurigemma's NPI, 1487637062, was assigned on November 28, 2005. Dr. Aurigemma graduated from Harvard Medical School in 1979. Dr. Aurigemma holds Massachusetts license 57838.

Dr. Aurigemma's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.

Dr. Aurigemma's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Aurigemma is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Aurigemma to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aurigemma practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Aurigemma's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Aurigemma is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Aurigemma's licenses on file in 4 states: Massachusetts, California, Connecticut and Pennsylvania.

Dmand AI lists aneurysm, angioplasty, atherosclerosis, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension and congestive heart failure among the conditions Dr. Aurigemma treats.

CMS data shows 2,801 Medicare services from Dr. Aurigemma across 14 procedure codes in 2024, for 2,151 Medicare patients. Medicare paid $65,774 for them.

CMS counts 2,151 Medicare patients who saw Dr. Aurigemma in 2024. The largest group is 65 to 74, with 767 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aurigemma's median patient age at 71, with 41% women.

In 2024, Dr. Aurigemma wrote 798 Medicare Part D claims for 186 patients. 91% of them were for generic drugs. CMS names the drug for 689 of them, across 18 drugs with 11 or more claims each, at $79,992 in total drug cost. In 2023, CMS named 589 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Aurigemma for performance year 2024, reported through an alternative payment model (APM). Dr. Aurigemma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 210 papers to Dr. Aurigemma, published from 2004 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Echocardiography, Ventricular Function, Left and Echocardiography, Doppler. Dr. Aurigemma has published most often in Am J Cardiol. Dr. Aurigemma's most frequent co-authors are David Dionne McManus, MD, Mayank Sardana, MD and Lara C. Kovell.

CMS Open Payments shows 17 general payments to Dr. Aurigemma from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 77% of the total. GE Healthcare paid the most, $13,934.

Dmand AI lists 3 awards for Dr. Aurigemma, most recently Regional Top Doctor in 2014.

Dr. Aurigemma graduated from Harvard Medical School in 1979. Dr. Aurigemma is a member of ACC.

Dr. Aurigemma is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.